Quantum Biopharma-B Sub VotQNTM
13F holders, Q3 2024 (September 30)12holders
$3.99avg. 13F price*
At the end of Q3 2024, 12 institutions reported holding Quantum Biopharma-B Sub Vot (QNTM) in their 13F filings. The largest holders were AdvisorShares Investments LLC ($105K), Virtu Financial LLC ($46K) and HRT Financial LP ($40K).
- Company
- Quantum Biopharma-B Sub Vot
- CUSIP
- 74764Y205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $192K |
| Exits | 0 | $0 |
Ownership 12 holders
| AdvisorShares Investments LLC | 0.02% | New | 26,233 | $105K |
| Virtu Financial LLC | 0.00% | New | 11,428 | $46K |
| HRT Financial LP | 0.00% | New | 10,041 | $40K |
| Group One Trading LLC | 0.00% | New | 172 | $688 |
| National Bank of Canada | 0.00% | New | 48 | $192 |
| Osaic Holdings, Inc. | 0.00% | New | 15 | $58 |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 14 | $55 |
| Avior Wealth Management, LLC | 0.00% | New | 3 | $12 |
| TD Waterhouse Canada Inc. | 0.00% | New | 3 | $11 |
| Bank of America Corp. | 0.00% | New | 1 | $4 |
| FMR LLC | 0.00% | New | 1 | $4 |
| Royal Bank of Canada | 0.00% | New | 107 | $0 |
"% of holder's portfolio" is QNTM's weight in each manager's 13F, not the share of Quantum Biopharma-B Sub Vot the manager owns.